trodelvy

Generic: sacituzumab govitecan

Labeler: gilead sciences, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name trodelvy
Generic Name sacituzumab govitecan
Labeler gilead sciences, inc.
Dosage Form POWDER, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

sacituzumab govitecan 180 mg/1

Manufacturer
Gilead Sciences, Inc.

Identifiers & Regulatory

Product NDC 55135-132
Product ID 55135-132_18d71575-4896-4cfe-a9e8-a90fbd8bdb8a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761115
Listing Expiration 2026-12-31
Marketing Start 2020-04-22

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55135132
Hyphenated Format 55135-132

Supplemental Identifiers

RxCUI
2360534 2360539
UNII
M9BYU8XDQ6

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name trodelvy (source: ndc)
Generic Name sacituzumab govitecan (source: ndc)
Application Number BLA761115 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 180 mg/1
source: ndc
Packaging
  • 1 VIAL in 1 BOX (55135-132-01) / 1 POWDER, FOR SOLUTION in 1 VIAL
source: ndc

Packages (1)

55135-132-01 1 VIAL in 1 BOX (55135-132-01) / 1 POWDER, FOR SOLUTION in 1 VIAL

Ingredients (1)

sacituzumab govitecan (180 mg/1)

Linked Drug Pages (1)

TRODELVY ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "18d71575-4896-4cfe-a9e8-a90fbd8bdb8a", "openfda": {"unii": ["M9BYU8XDQ6"], "rxcui": ["2360534", "2360539"], "spl_set_id": ["57a597d2-03f0-472e-b148-016d7169169d"], "manufacturer_name": ["Gilead Sciences, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 BOX (55135-132-01)  / 1 POWDER, FOR SOLUTION in 1 VIAL", "package_ndc": "55135-132-01", "marketing_start_date": "20200423"}], "brand_name": "TRODELVY", "product_id": "55135-132_18d71575-4896-4cfe-a9e8-a90fbd8bdb8a", "dosage_form": "POWDER, FOR SOLUTION", "product_ndc": "55135-132", "generic_name": "SACITUZUMAB GOVITECAN", "labeler_name": "Gilead Sciences, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TRODELVY", "active_ingredients": [{"name": "SACITUZUMAB GOVITECAN", "strength": "180 mg/1"}], "application_number": "BLA761115", "marketing_category": "BLA", "marketing_start_date": "20200422", "listing_expiration_date": "20261231"}